fluorodeoxyglucose f18 has been researched along with Adenocarcinoma, Clear Cell in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (26.09) | 29.6817 |
| 2010's | 12 (52.17) | 24.3611 |
| 2020's | 5 (21.74) | 2.80 |
| Authors | Studies |
|---|---|
| Guan, Y; Wang, J; Wu, J; Xie, F; Xu, J | 1 |
| Has Simsek, D; Kiran, MY; Kuyumcu, S; Sanli, Y | 1 |
| Liu, S; Wu, X; Xiang, L; Yang, H; Ye, S; Zhou, S | 1 |
| Koyasu, S; Minamiguchi, S; Nakamoto, Y; Otani, T; Togashi, K | 1 |
| Asano, R; Matsuura, T; Miyasaka, N; Otsuka, I; Ouchi, E; Ouchi, T | 1 |
| Chae, SY; Choi, HJ; Kim, HO; Kim, YT; Lee, JJ; Nam, JH; Park, JY; Song, IH; Sung, CO | 1 |
| Bernd, K; Gasparri, ML; Genoud, S; Mueller, MD; Papadia, A | 1 |
| Liu, S; Wu, X; Xiang, L; Yang, H; Ye, S | 1 |
| Arana Yi, C; Axelrod, R; Machtay, M; McCue, P; Morris, GJ; Rosen, M | 1 |
| Kojima, A; Konishi, H; Nogawa, T; Okame, S; Shiroyama, Y; Sugawara, Y; Takehara, K; Yamamoto, Y; Yokoyama, T | 1 |
| Nguyen, BD | 1 |
| Fanfani, F; Ferrandina, G; Gentileschi, S; Mattoli, MV; Palluzzi, E; Pennacchia, I; Scambia, G; Valentini, AL; Zannoni, G | 1 |
| Adachi, K; Arimoto, T; Eguchi, S; Fujii, T; Fujikawa, T; Fujimoto, A; Inoue, T; Kawana, K; Nagamatsu, T; Nakamura, H; Nishida, H; Oda, K; Ogishima, J; Osuga, Y; Sato, M; Taguchi, A; Tomio, K; Wada-Hiraike, O; Yamashita, A; Yoshida, M | 1 |
| Pietrzykowski, J; Wardyn, KA; Zielonka, TM | 1 |
| Bannier, M; Bats, AS; Brenot-Rossi, I; Ferron, G; Gauthier, H; Ghazzar, N; Houvenaeghel, G; Leblanc, E; Lecuru, F; Lumbroso, S; Morice, P; Narducci, F; Querleu, D; Uzan, C; Zerdoud, S | 1 |
| Dehdashti, F; Grigsby, PW; Schwarz, JK; Siegel, BA | 1 |
| Chung, HH; Chung, JK; Kang, KW; Kang, SB; Kim, JW; Kwon, HW; Park, NH; Song, YS | 1 |
| Berthelsen, AK; Engelholm, SA; Høgdall, C; Høgdall, E; Loft, A; Lundvall, L; Nedergaard, L; Risum, S | 1 |
| Grigsby, PW; Lin, LL; Miller, TR; Mutic, S; Yang, Z | 1 |
| Cherng, SC; Chiu, CS; Fan, YM; Liou, CH; Yuan, YN | 1 |
| Fukaya, T; Kohsaki, S; Maeda, N; Oguri, H; Yamada, R; Yamamoto, Y | 1 |
| Buttman, JA; Fuller, B; Hewitt, SM; Patronas, N; Poggi, MM | 1 |
| Futatsubashi, M; Kanno, T; Maeda, M; Nobezawa, S; Okada, H; Ouchi, Y; Takekuma, M; Torizuka, T; Yoshikawa, E | 1 |
1 review(s) available for fluorodeoxyglucose f18 and Adenocarcinoma, Clear Cell
| Article | Year |
|---|---|
Endometriosis-associated clear cell carcinoma arising in caesarean section scar: a case report and review of the literature.
Topics: Abdominal Wall; Adenocarcinoma, Clear Cell; Adult; Antibiotics, Antineoplastic; Biopsy, Fine-Needle; Cell Transformation, Neoplastic; Cesarean Section; Cicatrix; Doxorubicin; Endometrial Neoplasms; Endometriosis; Fatal Outcome; Female; Fluorodeoxyglucose F18; Humans; Hysterectomy; Laparoscopy; Liver Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoadjuvant Therapy; Ovariectomy; Pelvis; Polyethylene Glycols; Positron Emission Tomography Computed Tomography; Pregnancy; Rectus Abdominis; Salpingectomy | 2016 |
1 trial(s) available for fluorodeoxyglucose f18 and Adenocarcinoma, Clear Cell
| Article | Year |
|---|---|
Ovarian cancer recurrence: role of whole-body positron emission tomography using 2-[fluorine-18]-fluoro-2-deoxy- D-glucose.
Topics: Adenocarcinoma; Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Adult; Aged; CA-125 Antigen; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Granulosa Cell Tumor; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Postoperative Care; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Whole-Body Counting | 2002 |
21 other study(ies) available for fluorodeoxyglucose f18 and Adenocarcinoma, Clear Cell
| Article | Year |
|---|---|
Comparison of 68 Ga-FAPI and 18 F-FDG PET/CT in Finger Hidradenocarcinoma.
Topics: Adenocarcinoma, Clear Cell; Fingers; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Positron Emission Tomography Computed Tomography; Sweat Gland Neoplasms; Upper Extremity | 2023 |
18F-FDG and 68Ga-FAPI-04 PET/CT in Evaluating Clear-Cell Endometrial Cancer.
Topics: Adenocarcinoma, Clear Cell; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography | 2023 |
The role of 18F-FDG PET/CT-based quantitative metabolic parameters in patients with ovarian clear cell carcinoma.
Topics: Adenocarcinoma, Clear Cell; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Glucose; Glycolysis; Humans; Middle Aged; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tumor Burden | 2020 |
Hyperestrogenism on 18F-FDG PET/CT in a Patient With Estrogen-Producing Ovarian Clear Cell Carcinoma.
Topics: Adenocarcinoma, Clear Cell; Aged; Estrogens; Female; Fluorodeoxyglucose F18; Humans; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography | 2020 |
Pretreatment maximum standardized uptake value in 18F-fluorodeoxyglucose positron emission tomography-computed tomography as a prognostic factor for ovarian clear cell carcinoma and low-grade serous carcinoma.
Topics: Adenocarcinoma, Clear Cell; Adult; Aged; Aged, 80 and over; Cystadenocarcinoma, Serous; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Reference Standards; Reference Values; Retrospective Studies; Survival Rate; Young Adult | 2021 |
The Value of Preoperative Positron Emission Tomography/Computed Tomography in Node-Negative Endometrial Cancer on Magnetic Resonance Imaging.
Topics: Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Adult; Cystadenocarcinoma, Serous; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Preoperative Care; Prognosis; Radiopharmaceuticals; Survival Rate | 2017 |
The combination of preoperative PET/CT and sentinel lymph node biopsy in the surgical management of early-stage cervical cancer.
Topics: Adenocarcinoma, Clear Cell; Adult; Aged; Carcinoma, Adenosquamous; Carcinoma, Neuroendocrine; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sentinel Lymph Node; Sentinel Lymph Node Biopsy; Uterine Cervical Neoplasms | 2017 |
Topics: Adenocarcinoma, Clear Cell; Adult; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis | 2019 |
Sarcoidosis mimicking metastatic bone disease in head and neck cancer.
Topics: Adenocarcinoma, Clear Cell; Adult; Bone Neoplasms; Diagnosis, Differential; Ethmoid Sinus; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Neoplasm Metastasis; Positron-Emission Tomography; Sarcoidosis; Tomography, X-Ray Computed | 2013 |
Maximum standardized uptake value of fluorodeoxyglucose positron emission tomography/computed tomography is a prognostic factor in ovarian clear cell adenocarcinoma.
Topics: Adenocarcinoma, Clear Cell; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Ovarian Neoplasms; Positron-Emission Tomography; Prognosis; Reference Values; Retrospective Studies; Tomography, X-Ray Computed | 2014 |
Clear cell adenocarcinoma of the urethra: 18F-FDG PET/CT imaging.
Topics: Adenocarcinoma, Clear Cell; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Urethral Neoplasms | 2015 |
Low uptake of fluorodeoxyglucose in positron emission tomography/computed tomography in ovarian clear cell carcinoma may reflect glutaminolysis of its cancer stem cell-like properties.
Topics: Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Adult; Aged; Blotting, Western; Cystadenocarcinoma, Serous; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Glutamine; Humans; Middle Aged; Neoplasm Staging; Neoplastic Stem Cells; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Signal Transduction; Tumor Cells, Cultured; Young Adult | 2017 |
[PET-CT in evaluation of pulmonary nodule--case report].
Topics: Adenocarcinoma, Clear Cell; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Lung Diseases; Lung Neoplasms; Middle Aged; Neoplasms, Second Primary; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Solitary Pulmonary Nodule; Tomography, X-Ray Computed | 2009 |
Accuracy of 18-fluoro-2-deoxy-D-glucose positron emission tomography in the pretherapeutic detection of occult para-aortic node involvement in patients with a locally advanced cervical carcinoma.
Topics: Adenocarcinoma; Adenocarcinoma, Clear Cell; Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Child; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome; Uterine Cervical Neoplasms; Young Adult | 2011 |
Metabolic response on post-therapy FDG-PET predicts patterns of failure after radiotherapy for cervical cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Clear Cell; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Cervix Uteri; Cisplatin; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Treatment Failure; Uterine Cervical Neoplasms; Uterus; Young Adult | 2012 |
Prognostic value of preoperative metabolic tumor volume and total lesion glycolysis in patients with epithelial ovarian cancer.
Topics: Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Cystadenocarcinoma, Serous; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glycolysis; Humans; Middle Aged; Multimodal Imaging; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed | 2012 |
Positron emission tomography/computed tomography predictors of overall survival in stage IIIC/IV ovarian cancer.
Topics: Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Cystadenocarcinoma, Serous; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed | 2012 |
FDG-PET imaging for the assessment of physiologic volume response during radiotherapy in cervix cancer.
Topics: Adenocarcinoma, Clear Cell; Adult; Aged; Brachytherapy; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Uterine Cervical Neoplasms | 2006 |
Intense FDG uptake of metastatic clear cell carcinoma from the ovary in a uterine leiomyoma.
Topics: Adenocarcinoma, Clear Cell; Antigens, Neoplasm; Biomarkers, Tumor; CA-125 Antigen; Female; Fluorodeoxyglucose F18; Humans; Leiomyoma; Middle Aged; Neoplasms, Multiple Primary; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Neoplasms | 2006 |
Preoperative evaluation of pelvic masses with combined 18F-fluorodeoxyglucose positron emission tomography and computed tomography.
Topics: Adenocarcinoma; Adenocarcinoma, Clear Cell; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Ovarian Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
Intramedullary spinal cord metastasis from renal cell carcinoma: detection by positron emission tomography.
Topics: Adenocarcinoma, Clear Cell; Adult; Carcinoma, Renal Cell; Combined Modality Therapy; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Radionuclide Imaging; Radiopharmaceuticals; Spinal Cord Neoplasms; Tomography, X-Ray Computed; Whole-Body Counting | 2001 |